Uniqure reports that AMT-130 slows Huntington's disease
CureFFI.org,
Above: change in cUHDRS, the primary endpoint of Uniqure’s Huntington’s disease trial. If you’re anyone who spends time…
Above: change in cUHDRS, the primary endpoint of Uniqure’s Huntington’s disease trial. If you’re anyone who spends time…
In honor of Rare Disease Day 2022, February 28th, I’m reposting a DNA Science story from nine years ago. February 16th was 12…
Un grand nombre de maladies génétiques sont causées par des mutations ponctuelles, c'est-à-dire à l'échelle du nucléotide. Les mé…
Introduction It may seem like age of onset in genetic prion disease has been studied to death. For the past 25 years…